Results 101 to 110 of about 216,526 (119)

Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.

Circulation. Cardiovascular Interventions, 2019
BACKGROUND Recently, the Academic Research Consortium for High Bleeding Risk (ARC-HBR) has been proposed to standardize the definition of HBR, which was arbitrarily defined as a Bleeding Academic Research Consortium 3 or 5 bleeding ≥4% at 1-year. However,
M. Natsuaki, T. Morimoto, H. Shiomi, K. Yamaji, Hirotoshi Watanabe, S. Shizuta, Takao Kato, K. Ando, Y. Nakagawa, Y. Furukawa, T. Tada, K. Nagao, K. Kadota, M. Toyofuku, Takeshi Kimura   +14 more
semanticscholar   +1 more source

P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention

Nature Reviews Cardiology, 2022
D. Capodanno, U. Baber, Deepak L. Bhatt, J. Collet, G. Dangas, Francesco Franchi, C. Gibson, H. Gwon, A. Kastrati, Takeshi Kimura, P. Lemos, R. Lopes, R. Mehran, M. O’Donoghue, S. Rao, F. Rollini, P. Serruys, P. Steg, R. Storey, M. Valgimigli, P. Vranckx, Hirotoshi Watanabe, S. Windecker, D. Angiolillo   +23 more
semanticscholar   +1 more source

Bleeding avoidance strategies in percutaneous coronary intervention

Nature Reviews Cardiology, 2021
D. Capodanno, Deepak L. Bhatt, C. Gibson, S. James, Takeshi Kimura, R. Mehran, S. Rao, P. Steg, P. Urban, M. Valgimigli, S. Windecker, D. Angiolillo   +11 more
semanticscholar   +1 more source

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.

European Heart Journal, 2018
AIMS This study aims to examine the temporal trends and outcomes in patients who undergo percutaneous coronary intervention (PCI) with a previous or current diagnosis of cancer, according to cancer type and the presence of metastases.
Jessica Potts, C. Iliescu, Juan C Lopez Mattei, S. C. Martinez, L. Holmvang, P. Ludman, M. de Belder, C. Kwok, M. Rashid, D. Fischman, M. Mamas   +10 more
semanticscholar   +1 more source

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Journal of the American Medical Association (JAMA), 2002
S. Steinhubl, Peter B. Berger, J. Tift Mann III, Edward T. A. Fry, A. Delago, C. Wilmer, E. J. Topol   +6 more
semanticscholar   +1 more source

Treatment of chronic axial back pain with 60‐day percutaneous medial branch PNS: Primary end point results from a prospective, multicenter study

Pain Practice, 2021
Joseph W Boggs, Kasra Amirdelfan, Mehul J Desai   +2 more
exaly  

Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention.

Journal of the American College of Cardiology, 2020
Mahesh V. Madhavan, A. Kirtane, B. Redfors, P. Généreux, O. Ben-Yehuda, T. Palmerini, U. Benedetto, G. Biondi‐Zoccai, P. Smits, C. von Birgelen, R. Mehran, T. McAndrew, P. Serruys, M. Leon, S. Pocock, G. Stone   +15 more
semanticscholar   +1 more source

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

The Lancet, 2013
Friedrich W. Mohr, M. Morice, A. Kappetein, Ted E. Feldman, E. Ståhle, A. Colombo, M. J. Mack, David R. Holmes, M. Morel, Nic Van Dyck, Vicki M Houle, K. Dawkins, P. Serruys   +12 more
semanticscholar   +1 more source

Outcomes of Percutaneous and Paddle Lead Implantation for Spinal Cord Stimulation: A Comparative Analysis of Complications, Reoperation Rates, and Health-Care Costs

Neuromodulation, 2013
Kevin T Huang, Maxwell Boakye, John C Benson   +2 more
exaly  

Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review

BJU International, 2012
Grant D Stewart
exaly